Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Ascentage's lisaftoclax gets breakthrough therapy status in China for untreated CLL/SLLOct 21Regulatory milestoneAscentage Pharma Group International
Fred Hutchinson posts Phase II acalabrutinib results; AstraZeneca's AZD0780 LDL-C trial completesOct 16Weekly roundup, 11 itemsacalabrutinibAstraZenecaUpdated
AstraZeneca completes Phase 1 laroprovstat/ezetimibe bioavailability study in healthy adultsOct 2Weekly roundup, 6 itemsacalabrutinibanifrolumab-fnia
AstraZeneca week: Imfinzi label update, ASSURE CLL results posted, four trials registeredSep 3Weekly roundup, 6 itemsacalabrutinibAstraZeneca